Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease

BACKGROUND AND PURPOSE: To assess the long-term safety and efficacy of pramipexole as a once-daily (q.d.) extended-release oral formulation in early or advanced Parkinson's disease (PD). METHODS: In two double-blind (DB) studies of early PD and one of advanced PD, active-treatment arms received...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Neurol
Main Authors: Hauser, R A, Schapira, A H V, Barone, P, Mizuno, Y, Rascol, O, Busse, M, Debieuvre, C, Fraessdorf, M, Poewe, W, Pramipexole ER Studies Group
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282380/
https://ncbi.nlm.nih.gov/pubmed/24834511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.12375
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados